|
1
|
Detmers PA, Hernandez M, Mudgett J,
Hassing H, Burton C, Mundt S, Chun S, Fletcher D, Card DJ, Lisnock
J, et al: Deficiency in inducible nitric oxide synthase results in
reduced atherosclerosis in apolipoprotein E-deficient mice. J
Immunol. 165:3430–3435. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schmitz G, Kaminski WE, Porsch-Ozcürümez
M, Klucken J, Orsó E, Bodzioch M, Büchler C and Drobnik W:
ATP-binding cassette transporter A1 (ABCA1) in macrophages: A dual
function in inflammation and lipid metabolism? Pathobiology.
67:236–240. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bodzioch M, Orsó E, Klucken J, Langmann T,
Böttcher A, Diederich W, Drobnik W, Barlage S, Büchler C,
Porsch-Ozcürümez M, et al: The gene encoding ATP-binding cassette
transporter 1 is mutated in Tangier disease. Nat Genet. 22:347–351.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Glass CK and Witztum JL: Atherosclerosis.
The road ahead. Cell. 104:503–516. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu XH, Fu YC, Zhang DW, Yin K and Tang CK:
Foam cells in atherosclerosis. Clin Chim Acta. 424:245–252. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Favari E, Zimetti F, Bortnick AE, Adorni
MP, Zanotti I, Canavesi M and Bernini F: Impaired ATP-binding
cassette transporter A1-mediated sterol efflux from oxidized
LDL-loaded macrophages. FEBS Lett. 579:6537–6542. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Berrougui H, Ikhlef S and Khalil A: Extra
virgin olive oil polyphenols promote cholesterol efflux and improve
HDL functionality. Evid Based Complement Alternat Med.
2015:2080622015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Escolà-Gil JC, Llaverias G, Julve J,
Jauhiainen M, Méndez-González J and Blanco-Vaca F: The cholesterol
content of Western diets plays a major role in the paradoxical
increase in high-density lipoprotein cholesterol and upregulates
the macrophage reverse cholesterol transport pathway. Arterioscler
Thromb Vasc Biol. 31:2493–2499. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao GJ, Yin K, Fu YC and Tang CK: The
interaction of ApoA-I and ABCA1 triggers signal transduction
pathways to mediate efflux of cellular lipids. Mol Med. 18:149–158.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JY, Karwatsky J, Ma L and Zha X: ABCA1
increases extracellular ATP to mediate cholesterol efflux to
ApoA-I. Am J Physiol Cell Physiol. 301:C886–C894. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ji A, Wroblewski JM, Cai L, de Beer MC,
Webb NR and van der Westhuyzen DR: Nascent HDL formation in
hepatocytes and role of ABCA1, ABCG1, and SR-BI. J Lipid Res.
53:446–455. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chawla A, Boisvert WA, Lee CH, Laffitte
BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, et
al: A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in
cholesterol efflux and atherogenesis. Mol Cell. 7:161–171. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim SH, Han SY, Azam T, Yoon DY and
Dinarello CA: Interleukin-32: A cytokine and inducer of TNFalpha.
Immunity. 22:131–142. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Choi JD, Bae SY, Hong JW, Azam T,
Dinarello CA, Her E, Choi WS, Kim BK, Lee CK, Yoon DY, et al:
Identification of the most active interleukin-32 isoform.
Immunology. 126:535–542. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheon S, Lee JH, Park S, Bang SI, Lee WJ,
Yoon DY, Yoon SS, Kim T, Min H, Cho BJ, et al: Overexpression of
IL-32alpha increases natural killer cell-mediated killing through
up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression
in human chronic myeloid leukemia cells. J Biol Chem.
286:12049–12055. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Goda C, Kanaji T, Kanaji S, Tanaka G,
Arima K, Ohno S and Izuhara K: Involvement of IL-32 in
activation-induced cell death in T cells. Int Immunol. 18:233–240.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim S: interleukin-32 in inflammatory
autoimmune diseases. Immune Netw. 14:123–127. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Conti P and Shaik-Dasthagirisaeb Y:
Atherosclerosis: A chronic inflammatory disease mediated by mast
cells. Cent Eur J Immunol. 40:380–386. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Buckley ML and Ramji DP: The influence of
dysfunctional signaling and lipid homeostasis in mediating the
inflammatory responses during atherosclerosis. Biochim Biophys
Acta. 1852:1498–1510. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Majdalawieh A and Ro HS: PPARgamma1 and
LXRalpha face a new regulator of macrophage cholesterol homeostasis
and inflammatory responsiveness, AEBP1. Nucl Recept Signal.
8:e0042010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ramji DP and Davies TS: Cytokines in
atherosclerosis: Key players in all stages of disease and promising
therapeutic targets. Cytokine Growth Factor Rev. 26:673–685. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang N, Lei J, Lei H, Ruan X, Liu Q, Chen
Y and Huang W: MicroRNA-101 overexpression by IL-6 and TNF-α
inhibits cholesterol efflux by suppressing ATP-binding cassette
transporter A1 expression. Exp Cell Res. 336:33–42. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ruan XZ, Moorhead JF, Fernando R, Wheeler
DC, Powis SH and Varghese Z: PPAR agonists protect mesangial cells
from interleukin 1beta-induced intracellular lipid accumulation by
activating the ABCA1 cholesterol efflux pathway. J Am Soc Nephrol.
14:593–600. 2003. View Article : Google Scholar : PubMed/NCBI
|
